US Stock MarketDetailed Quotes

PURE BIOSCIENCE (PURE)

Watchlist
  • 0.0640
  • -0.0044-6.41%
15min DelayClose May 13 14:33 ET
7.16MMarket Cap-3.20P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

PURE BIOSCIENCE (PURE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jan 31, 2026
(Q1)Oct 31, 2025
(FY)Jul 31, 2025
(Q4)Jul 31, 2025
(Q3)Apr 30, 2025
(Q2)Jan 31, 2025
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11.40%-606K
50.30%-250K
20.39%-2.02M
23.10%-456K
16.75%-512K
38.39%-544K
-14.32%-503K
22.79%-2.53M
20.30%-593K
7.52%-615K
Net income from continuing operations
1.63%-785K
32.66%-464K
28.39%-2.4M
56.08%-332K
32.32%-580K
20.36%-798K
6.26%-689K
15.43%-3.35M
26.74%-756K
2.17%-857K
Depreciation and amortization
0.00%1K
--1K
-98.65%2K
--0
-97.22%1K
-97.30%1K
--0
26.50%148K
153.33%38K
2.86%36K
Change In working capital
-46.90%120K
38.76%179K
-40.81%235K
-277.01%-154K
-70.18%34K
1,155.56%226K
-27.53%129K
471.03%397K
202.35%87K
58.33%114K
-Change in receivables
-28.27%137K
216.44%85K
-1,253.85%-176K
-192.19%-187K
-69.84%-107K
8.52%191K
-17.74%-73K
84.52%-13K
34.02%-64K
-96.88%-63K
-Change in inventory
-133.33%-7K
-500.00%-96K
-365.63%-85K
-155.56%-10K
---56K
-110.00%-3K
0.00%-16K
-43.86%32K
-73.13%18K
--0
-Change in prepaid assets
82.35%31K
10.00%-18K
-88.24%4K
-158.82%-10K
-5.56%17K
-55.26%17K
48.72%-20K
179.07%34K
170.83%17K
238.46%18K
-Change in payables and accrued expense
-295.24%-41K
-12.61%208K
43.02%492K
-54.31%53K
13.21%180K
109.29%21K
-19.32%238K
1,029.73%344K
474.19%116K
50.00%159K
Cash from discontinued investing activities
Operating cash flow
-11.40%-606K
50.30%-250K
20.39%-2.02M
23.10%-456K
16.75%-512K
38.39%-544K
-14.32%-503K
22.79%-2.53M
20.30%-593K
7.52%-615K
Investing cash flow
Cash flow from continuing investing activities
0
0
Net PPE purchase and sale
----
----
----
----
----
----
----
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
----
----
----
----
----
----
----
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
-7.50%370K
-30.00%350K
12.04%2M
-50.00%250K
70.00%850K
400K
-36.31%500K
75.86%1.79M
-50.74%500K
500K
Net issuance payments of debt
-7.50%370K
-30.00%350K
12.04%2M
-50.00%250K
70.00%850K
--400K
-36.31%500K
75.86%1.79M
-50.74%500K
--500K
Cash from discontinued financing activities
Financing cash flow
-7.50%370K
-30.00%350K
12.04%2M
-50.00%250K
70.00%850K
--400K
-36.31%500K
75.86%1.79M
-50.74%500K
--500K
Net cash flow
Beginning cash position
20.90%509K
-3.54%409K
-63.76%424K
18.96%615K
-56.17%277K
-72.21%421K
-63.76%424K
-66.24%1.17M
-39.60%517K
-59.49%632K
Current changes in cash
-63.89%-236K
3,433.33%100K
97.99%-15K
-121.51%-206K
393.91%338K
83.69%-144K
-100.87%-3K
67.51%-746K
-129.62%-93K
83.66%-115K
End cash Position
-1.44%273K
20.90%509K
-3.54%409K
-3.54%409K
18.96%615K
-56.17%277K
-72.21%421K
-63.76%424K
-63.76%424K
-39.60%517K
Free cash flow
-11.40%-606K
50.30%-250K
20.39%-2.02M
23.10%-456K
16.75%-512K
38.39%-544K
-14.32%-503K
23.56%-2.53M
15.41%-593K
12.64%-615K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jan 31, 2026(Q1)Oct 31, 2025(FY)Jul 31, 2025(Q4)Jul 31, 2025(Q3)Apr 30, 2025(Q2)Jan 31, 2025(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11.40%-606K50.30%-250K20.39%-2.02M23.10%-456K16.75%-512K38.39%-544K-14.32%-503K22.79%-2.53M20.30%-593K7.52%-615K
Net income from continuing operations 1.63%-785K32.66%-464K28.39%-2.4M56.08%-332K32.32%-580K20.36%-798K6.26%-689K15.43%-3.35M26.74%-756K2.17%-857K
Depreciation and amortization 0.00%1K--1K-98.65%2K--0-97.22%1K-97.30%1K--026.50%148K153.33%38K2.86%36K
Change In working capital -46.90%120K38.76%179K-40.81%235K-277.01%-154K-70.18%34K1,155.56%226K-27.53%129K471.03%397K202.35%87K58.33%114K
-Change in receivables -28.27%137K216.44%85K-1,253.85%-176K-192.19%-187K-69.84%-107K8.52%191K-17.74%-73K84.52%-13K34.02%-64K-96.88%-63K
-Change in inventory -133.33%-7K-500.00%-96K-365.63%-85K-155.56%-10K---56K-110.00%-3K0.00%-16K-43.86%32K-73.13%18K--0
-Change in prepaid assets 82.35%31K10.00%-18K-88.24%4K-158.82%-10K-5.56%17K-55.26%17K48.72%-20K179.07%34K170.83%17K238.46%18K
-Change in payables and accrued expense -295.24%-41K-12.61%208K43.02%492K-54.31%53K13.21%180K109.29%21K-19.32%238K1,029.73%344K474.19%116K50.00%159K
Cash from discontinued investing activities
Operating cash flow -11.40%-606K50.30%-250K20.39%-2.02M23.10%-456K16.75%-512K38.39%-544K-14.32%-503K22.79%-2.53M20.30%-593K7.52%-615K
Investing cash flow
Cash flow from continuing investing activities 00
Net PPE purchase and sale ------------------------------0--0----
Cash from discontinued investing activities
Investing cash flow ------------------------------0--0----
Financing cash flow
Cash flow from continuing financing activities -7.50%370K-30.00%350K12.04%2M-50.00%250K70.00%850K400K-36.31%500K75.86%1.79M-50.74%500K500K
Net issuance payments of debt -7.50%370K-30.00%350K12.04%2M-50.00%250K70.00%850K--400K-36.31%500K75.86%1.79M-50.74%500K--500K
Cash from discontinued financing activities
Financing cash flow -7.50%370K-30.00%350K12.04%2M-50.00%250K70.00%850K--400K-36.31%500K75.86%1.79M-50.74%500K--500K
Net cash flow
Beginning cash position 20.90%509K-3.54%409K-63.76%424K18.96%615K-56.17%277K-72.21%421K-63.76%424K-66.24%1.17M-39.60%517K-59.49%632K
Current changes in cash -63.89%-236K3,433.33%100K97.99%-15K-121.51%-206K393.91%338K83.69%-144K-100.87%-3K67.51%-746K-129.62%-93K83.66%-115K
End cash Position -1.44%273K20.90%509K-3.54%409K-3.54%409K18.96%615K-56.17%277K-72.21%421K-63.76%424K-63.76%424K-39.60%517K
Free cash flow -11.40%-606K50.30%-250K20.39%-2.02M23.10%-456K16.75%-512K38.39%-544K-14.32%-503K23.56%-2.53M15.41%-593K12.64%-615K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -